PMA P040005S005

Device
HER2 FISH PHARMDX KIT
Applicant
Agilent Technologies Singapore (International) Pte , Ltd.
PMA number
P040005
Supplement
S005
Product code
MVD
Decision date
2010-10-20
Classification
System, Test, Her-2/neu, Nucleic Acid Or Serum
Generic name
SYSTEM, TEST, HER-2/NEU, NUCLEIC ACID OR SERUM
Approval order statement
APPROVAL FOR THE HER2 FISH PHARMDX KIT. THE DEVICE IS INDICATED FOR IN VITRO DIAGNOSTIC USE. THE HER2 FISH PHARMDX KIT IS A DIRECT FLUORESCENCE IN SITU HYBRIDIZATION (FISH) ASSAY DESIGNED TO QUANTITATIVELY DETERMINE HER2 GENE AMPLIFICATION IN FORMALIN-FIXED, PARAFFIN-EMBEDDED (FFPE) BREAST CANCER TISSUE SPECIMENS AND FFPE SPECIMENS FROM PATIENTS WITH METASTATIC GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA. HER2 FISH PHARMDX KIT IS INDICATED AS AN AID IN THE ASSESSMENT OF PATIENTS FOR WHOM HERCEPTIN (TRASTUZUMAB) TREATMENT IS BEING CONSIDERED (SEE HERCEPTIN PACKAGE INSERT).
Summary
<a href="http://www.accessdata.fda.gov/cdrh_docs/pdf4/P040005S005B.pdf" target="_new">Summary of Safety and Effectiveness</a>

Current openFDA PMA Record#

Device
HER2 FISH PHARMDX KIT
Applicant
Agilent Technologies Singapore (International) Pte , Ltd.
PMA number
P040005
Supplement
S005
Product code
MVD
Generic name
SYSTEM, TEST, HER-2/NEU, NUCLEIC ACID OR SERUM
Decision date
2010-10-20
Decision code
APPR
Date received
2010-04-20
Supplement type
Panel Track
Approval order statement
APPROVAL FOR THE HER2 FISH PHARMDX KIT. THE DEVICE IS INDICATED FOR IN VITRO DIAGNOSTIC USE. THE HER2 FISH PHARMDX KIT IS A DIRECT FLUORESCENCE IN SITU HYBRIDIZATION (FISH) ASSAY DESIGNED TO QUANTITATIVELY DETERMINE HER2 GENE AMPLIFICATION IN FORMALIN-FIXED, PARAFFIN-EMBEDDED (FFPE) BREAST CANCER TISSUE SPECIMENS AND FFPE SPECIMENS FROM PATIENTS WITH METASTATIC GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA. HER2 FISH PHARMDX KIT IS INDICATED AS AN AID IN THE ASSESSMENT OF PATIENTS FOR WHOM HERCEPTIN (TRASTUZUMAB) TREATMENT IS BEING CONSIDERED (SEE HERCEPTIN PACKAGE INSERT).